Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma

NCT02364076 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Thymic Carcinoma
Thymus Neoplasms
Thymus Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Epacadostat

Sponsor

Georgetown University

Collaborators

[object Object]
[object Object]